P

Inventor

SUBRAMANYAM CHAKRAPANI

US59 patents
⚠️ This page may combine multiple inventors who share the name “SUBRAMANYAM CHAKRAPANI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PFIZER

25 patents
US8828401B2Sep 9, 2014

Cytotoxic peptides and antibody drug conjugates thereof

PFIZER35 citations92
US9133190B2Sep 15, 2015

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER8 citations84
US8822494B2Sep 2, 2014

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER12 citations84
US9249186B2Feb 2, 2016

Cytotoxic peptides and antibody drug conjugates thereof

PFIZER7 citations82
US9138486B2Sep 22, 2015

Cytotoxic peptides and antibody drug conjugates thereof

PFIZER7 citations82
US8916564B2Dec 23, 2014

Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders

PFIZER6 citations82
US9504669B2Nov 29, 2016

Spliceostatin analogs and methods for their preparation

PFIZER5 citations80
US9169264B2Oct 27, 2015

Spliceostatin analogs and methods for their preparation

PFIZER8 citations80
US9688698B2Jun 27, 2017

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER4 citations73
US9540352B2Jan 10, 2017

Substituted 1,7-naphthyridines as dopamine D1 ligands

PFIZER5 citations73
US9527843B2Dec 27, 2016

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER3 citations73
US9617275B2Apr 11, 2017

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER5 citations68
US10086085B2Oct 2, 2018

Bifunctional cytotoxic agents

PFIZER2 citations67
US7235549B2Jun 26, 2007

Benzamide, heteroarylamide and reverse amides

PFIZER4 citations63
US9856263B2Jan 2, 2018

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER2 citations62
US7186742B2Mar 6, 2007

Benzamide inhibitors of the P2X7 receptor

PFIZER4 citations62
US7071223B1Jul 4, 2006

Benzamide inhibitors of the P2X7 receptor

PFIZER2 citations62
US9751877B2Sep 5, 2017

Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders

PFIZER1 citations60
US11365263B2Jun 21, 2022

Bifunctional cytotoxic agents containing the CTI pharmacophore

PFIZER0 citations59
US9067934B2Jun 30, 2015

Bicyclic pyridinones

PFIZER2 citations59
US11993625B2May 28, 2024

Calicheamicin derivatives and antibody drug conjugates thereof

PFIZER1 citations56
US11833216B2Dec 5, 2023

Anti-EDB antibodies and antibody-drug conjugates

PFIZER0 citations56
US10077272B2Sep 18, 2018

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER0 citations52
US9868744B2Jan 16, 2018

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER1 citations52
US9850232B2Dec 26, 2017

Heteroaromatic compounds and their use as dopamine D1 ligands

PFIZER1 citations52

STERLING WINTHROP INC

18 patents
US5236917AAug 17, 1993

Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof

STERLING WINTHROP INC135 citations98
US5596012AJan 21, 1997

Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof

STERLING WINTHROP INC68 citations96
US5371074ADec 6, 1994

Use of saccharin derivatives as proteolytic enzyme inhibitors

STERLING WINTHROP INC65 citations96
US5569655AOct 29, 1996

Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof

STERLING WINTHROP INC59 citations95
US5488062AJan 30, 1996

2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof

STERLING WINTHROP INC23 citations92
US5455248AOct 3, 1995

Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts, and compositions and method of use thereof

STERLING WINTHROP INC27 citations92
US5376653ADec 27, 1994

2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors

STERLING WINTHROP INC4 citations74
US5306818AApr 26, 1994

Tetrahydro 2-saccharinylmerthyl aryl carboxylates

STERLING WINTHROP INC11 citations74
US5187173AFeb 16, 1993

2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof

STERLING WINTHROP INC7 citations74
US5554620ASep 10, 1996

Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof

STERLING WINTHROP INC7 citations73
US5250696AOct 5, 1993

2-saccharinylmethyl aryl carboxylate

STERLING WINTHROP INC10 citations73
US5128339AJul 7, 1992

Proteolytic enzyme inhibition method

STERLING WINTHROP INC17 citations73
US5578623ANov 26, 1996

Saccharin derivative proteolytic enzyme inhibitors

STERLING WINTHROP INC4 citations63
US5563163AOct 8, 1996

2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof

STERLING WINTHROP INC2 citations63
US5464852ANov 7, 1995

Saccharin derivative proteolytic enzyme inhibitors

STERLING WINTHROP INC1 citations63
US5597841AJan 28, 1997

2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof

STERLING WINTHROP INC3 citations62
US5512589AApr 30, 1996

2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof

STERLING WINTHROP INC5 citations62
US5380737AJan 10, 1995

Saccharin derivative proteolytic enzyme inhibitors

STERLING WINTHROP INC3 citations60

SANOFI SA

3 patents

SUBRAMANYAM CHAKRAPANI

1 patent

PETTERSSON MARTIN YOUNGJIN

1 patent

BUTLER TODD W

1 patent

PFIZER PROD INC

1 patent

Showing the top 50 of 59 patents by PatentIndex Score.